ZNF828 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.882000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.013000E-01
Normal-vs-Stage2
3.239800E-02
Normal-vs-Stage3
5.443700E-02
Normal-vs-Stage4
7.382600E-01
Stage1-vs-Stage2
1.583010E-01
Stage1-vs-Stage3
1.327800E-02
Stage1-vs-Stage4
5.544200E-01
Stage2-vs-Stage3
1.112830E-01
Stage2-vs-Stage4
6.858000E-02
Stage3-vs-Stage4
1.908270E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.392200E-02
Normal-vs-AfricanAmerican
4.957200E-01
Normal-vs-Asian
3.772100E-02
Caucasian-vs-AfricanAmerican
9.821800E-02
Caucasian-vs-Asian
3.084400E-01
AfricanAmerican-vs-Asian
6.306400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.059500E-02
Normal-vs-Female
5.570000E-02
Male-vs-Female
3.177800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.374600E-01
Normal-vs-Age(41-60Yrs)
5.183500E-02
Normal-vs-Age(61-80Yrs)
3.275800E-02
Normal-vs-Age(81-100Yrs)
4.809600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.216000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.654400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.417600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.423800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.522200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.636600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.904900E-03
Normal-vs-Daily Drinker
6.304400E-03
Normal-vs-Weekly Drinker
9.618200E-02
Normal-vs-Occasional Drinker
6.421900E-02
Normal-vs-Social Drinker
8.237900E-02
Non Drinker-vs-Daily Drinker
4.111200E-01
Non Drinker-vs-Weekly Drinker
2.322200E-01
Non Drinker-vs-Occasional Drinker
2.385600E-01
Non Drinker-vs-Social Drinker
1.518640E-01
Daily Drinker-vs-Weekly Drinker
8.764500E-02
Daily Drinker-vs-Occasional Drinker
8.039900E-02
Daily Drinker-vs-Social Drinker
4.980100E-02
Weekly Drinker-vs-Occasional Drinker
9.180400E-01
Weekly Drinker-vs-Social Drinker
8.924800E-01
Occasional Drinker-vs-Social Drinker
7.977400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.445560E-01
Normal-vs-Grade 2
1.831960E-02
Normal-vs-Grade 3
2.902400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.533800E-01
Grade 1-vs-Grade 3
5.249000E-01
Grade 1-vs-Grade 4
1.445560E-01
Grade 2-vs-Grade 3
9.375000E-01
Grade 2-vs-Grade 4
1.831960E-02
Grade 3-vs-Grade 4
2.902400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.431900E-02
Normal-vs-NonDiabetic
9.040700E-03
Diabetic-vs-NonDiabetic
8.230000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.399530E-02
Normal-vs-NoPancreatitis
1.527710E-02
Pancreatitis-vs-NoPancreatitis
2.270800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.960200E-02
Normal-vs-N1
3.426300E-02
N0-vs-N1
6.842800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.315700E-02
Normal-vs-TP53-NonMutant
1.617230E-01
TP53-Mutant-vs-TP53-NonMutant
3.771000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
